title: Response to "A graphic reanalysis of the NINDS Trial".
authors.forename: Helen M
authors.initials: HM
authors.lastname: Dewey
authors.forename: Leonid
authors.initials: L
authors.lastname: Churilov
authors.forename: David
authors.initials: D
authors.lastname: Blacker
authors.forename: Christopher
authors.initials: C
authors.lastname: Bladin
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Davis
authors.forename: Geoffrey A
authors.initials: GA
authors.lastname: Donnan
authors.forename: Peter
authors.initials: P
authors.lastname: Gates
authors.forename: Richard P
authors.initials: RP
authors.lastname: Gerraty
authors.forename: Peter
authors.initials: P
authors.lastname: Hand
authors.forename: Christopher
authors.initials: C
authors.lastname: Levi
authors.forename: Richard I
authors.initials: RI
authors.lastname: Lindley
authors.forename: Romesh
authors.initials: R
authors.lastname: Markus
authors.forename: Stephen
authors.initials: S
authors.lastname: Read
mesh_terms: D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D003627:Data Interpretation, Statistical; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator